170 related articles for article (PubMed ID: 28124528)
1. Can neutrophil to lymphocyte ratio predict lamina propria invasion in patients with non muscle invasive bladder cancer?
Cimen HI; Halis F; Saglam HS; Gokce A
Int Braz J Urol; 2017; 43(1):67-72. PubMed ID: 28124528
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
Mano R; Baniel J; Shoshany O; Margel D; Bar-On T; Nativ O; Rubinstein J; Halachmi S
Urol Oncol; 2015 Feb; 33(2):67.e1-7. PubMed ID: 25060672
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study.
Favilla V; Castelli T; Urzì D; Reale G; Privitera S; Salici A; Russo GI; Cimino S; Morgia G
Int Braz J Urol; 2016; 42(4):685-93. PubMed ID: 27564278
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
5. The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking.
Ogihara K; Kikuchi E; Yuge K; Yanai Y; Matsumoto K; Miyajima A; Asakura H; Oya M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1039-1047. PubMed ID: 27660257
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio is elevated in recurringnonmuscle invasive bladder cancer.
Yürük E; Saitz TR; Gönültaş S; Şerefoğlu EC; Müslümanoğlu AY
Turk J Med Sci; 2017 Feb; 47(1):234-239. PubMed ID: 28263495
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis.
Vartolomei MD; Porav-Hodade D; Ferro M; Mathieu R; Abufaraj M; Foerster B; Kimura S; Shariat SF
Urol Oncol; 2018 Sep; 36(9):389-399. PubMed ID: 29884342
[TBL] [Abstract][Full Text] [Related]
9. Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.
Cantiello F; Russo GI; Vartolomei MD; Farhan ARA; Terracciano D; Musi G; Lucarelli G; Di Stasi SM; Hurle R; Serretta V; Busetto GM; Scafuro C; Perdonà S; Borghesi M; Schiavina R; Cioffi A; De Berardinis E; Almeida GL; Bove P; Lima E; Ucciero G; Matei DV; Crisan N; Verze P; Battaglia M; Guazzoni G; Autorino R; Morgia G; Damiano R; de Cobelli O; Mirone V; Shariat SF; Ferro M
Eur Urol Oncol; 2018 Oct; 1(5):403-410. PubMed ID: 31158079
[TBL] [Abstract][Full Text] [Related]
10. Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
Racioppi M; Di Gianfrancesco L; Ragonese M; Palermo G; Sacco E; Bassi PF
Int Braz J Urol; 2019; 45(2):315-324. PubMed ID: 30785697
[TBL] [Abstract][Full Text] [Related]
11. Correlation of neutrophil-lymphocyte ratio and risk scores in non-muscle invasive bladder cancer.
Aydın M; Bitkin A; Kadıhasanoğlu M; İrkılata L; Akgüneş E; Keleş M; Atilla MK
Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):503-508. PubMed ID: 31164309
[TBL] [Abstract][Full Text] [Related]
12. Can the neutrophil-to-lymphocyte ratio be used to predict recurrence and progression of non-muscle-invasive bladder cancer?
Albayrak S; Zengin K; Tanik S; Atar M; Unal SH; Imamoglu MA; Gurdal M
Kaohsiung J Med Sci; 2016 Jun; 32(6):327-33. PubMed ID: 27377847
[TBL] [Abstract][Full Text] [Related]
13. Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder Cancer.
Vartolomei MD; Ferro M; Cantiello F; Lucarelli G; Di Stasi S; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdona S; Verze P; La Rocca R; Borghesi M; Schiavina R; Brunocilla E; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Battaglia M; Serretta V; Russo GI; Morgia G; Terracciano D; Musi G; de Cobelli O; Mirone V; Shariat SF
Clin Genitourin Cancer; 2018 Dec; 16(6):445-452. PubMed ID: 30077463
[TBL] [Abstract][Full Text] [Related]
14. Preoperative High Neutrophil-to-Lymphocyte Ratio Is Associated with High-grade Bladder Cancer.
Tang X; Wang S; An C; Du P; Yang Y
Anticancer Res; 2017 Aug; 37(8):4659-4663. PubMed ID: 28739768
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer.
Mbeutcha A; Shariat SF; Rieken M; Rink M; Xylinas E; Seitz C; Lucca I; Mathieu R; Rouprêt M; Briganti A; Karakiewicz PI; Klatte T
Urol Oncol; 2016 Nov; 34(11):483.e17-483.e24. PubMed ID: 27646875
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
[TBL] [Abstract][Full Text] [Related]
17. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil-to-lymphocyte ratio (NLR) may be predictive of pathologic stage in patients with bladder cancer larger than 3 cm.
Celik O; Akand M; Keskin MZ; Yoldas M; Ilbey YO
Eur Rev Med Pharmacol Sci; 2016; 20(4):652-6. PubMed ID: 26957266
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer invasion predictability based on preoperative neutrophil-lymphocyte ratio.
Kaynar M; Yıldırım ME; Badem H; Caviş M; Tekinarslan E; Istanbulluoğlu MO; Karataş ÖF; Çimentepe E
Tumour Biol; 2014 Jul; 35(7):6601-5. PubMed ID: 24696263
[TBL] [Abstract][Full Text] [Related]
20. Are the preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio predictive for lamina propria invasion in aging patients?
Atik YT; Cimen HI; Gul D; Arslan S; Kose O; Halis F
Aging Male; 2020 Dec; 23(5):1528-1532. PubMed ID: 33183143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]